Flywheel, the research informatics company, announces the deployment of its medical imaging research platform at Columbia University on Google Cloud Platform (GCP). The Flywheel platform has been used by the Columbia neuroscience and biomedical imaging community and their internal and external collaborators at Columbia’s Mortimer B. Zuckerman Mind Brain Behavior Institute since June 2017. With rapid user adoption and increased demands for largescale data management and computation, Columbia has expanded the Flywheel program and migrated to Google Cloud.
Innovative combination improves access, lowers cost and meets patients’ needs through technology and telehealth.
GeneMatters and Clear Genetics today announced they will offer a joint service that combines chatbots with live genetic counselors. The arrangement will help healthcare organizations enable more patients to receive genetic counseling in a consistent, timely and affordable manner, while allowing patients to drive the level of service they need.
OneOme, co-developed by Mayo Clinic, today announced several significant enhancements to its product offering, including the addition of four new genes (HLA-A, HLA-B, CYP4F2, and CYP2C Cluster) and nine new medications to its RightMed® comprehensive test, a pharmacogenomic (PGx) test that analyzes a patient’s DNA to predict how they will respond to hundreds of medications. In addition to these updates, OneOme now gives providers the option to order the MTHFR gene as a complimentary add-on to the RightMed test.
Save the date for our a spring investor open house. The event will be held Tuesday, May 15 from 5:00 - 7:30 PM. We look forward to seeing you and sharing the exciting progress of our portfolio companies.
MINNEAPOLIS, Feb 21, 2018 Invenshure portfolio company, OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications, announced it was named to Fast Company's World's 50 Most Innovative Companies list, as well as the Top 10 Most Innovative Companies in Biotech for 2018 in the publication's annual issue. OneOme numbered second in the Top 10 in biotech category and 22nd of 50 in the overall list.